nanoparticles for nanomedicine neil s. forbes nanotechnology institute university of massachusetts,...
TRANSCRIPT
Nanoparticles for Nanomedicine
Neil S. Forbes
Nanotechnology Institute
University of Massachusetts, Amherst
July 24, 2009
University of MassachusettsChemical Engineering
Targeted Delivery to Tumors
Many Different Length Scales
10cm
1cm
100m
1m
Relative Size of Nanoparticles
Nanoparticle with a 2 nm core and an octanethiol functionalized monolayer
Making Gold Nanoparticles
HAuCl4NaBH4
HS
S
S
S
SS
SSSSSS
SS SS
S
HS
HS
S
S
S
SS
SSSSSS
SS SS
S
HSS
S
S
SS
SSSSSS
SS SS
S
HSHS
• AuCl4- salts are reduced using NaBH4 in the presence of thiol capping ligands
• The core size of the particles formed can be varied from <1 nm to ~ 8 nm
• The surface functionality can be controlled through the choice of thiols
Fluorophores and Drugs Selectively Dissociate Inside Cells
Control of Surface Charge
Au SFITC
S
COO-
S
NMe3+
3
3
3O
~1 nm
2~5 nm
OC9
C9
C9
O
DrugorAu S
FITC
S
COO-
S
NMe3+
3
3
3O
~1 nm
2~5 nm
OC9
C9
C9
O
Drugor
Investigating Delivery Using Cylindroids
100 mPlug
WellPlate
MicroscopeObjective
Cylindroid
Viable
Dead
Nanoparticles in Cylindroids
Nanoparticle Diffusion
0
10
20
30
40
50
FITC Positive Negative
D x
10^
7 (c
m2/
sec)
4hrs
24hrs
dc
a
x
y
b
D×
107 cm
2 /se
c
0
0.2
0.4
0.6
0.8
1
0 2000 4000 6000
µm
Nor
mal
ized
Int
ensi
ty
6hrs12hrs18hrs24hrs
Modeling Particle Diffusion
Predicting Behavior in Tumors
Delivery of Doxorubicin
How Does Particle Charge Affect Tissue Penetration?
Transcellular
Paracellular
Cells
A
B
Engineering Approach: Targeted Intratumoral Therapy
• Quantify tumor microenvironments
• Develop vectors to target tumor quiescence
NecroticQuiescentProliferating
Therapeutic
Microenvironments in CylindroidsV
iabi
lity
A
crid
ine
Ora
nge
Scale bar is 100 µm Kasinskas, Forbes. 2006. Biotech Bioeng, 94:710
Bacteria Accumulate in Mouse Tumors
0
1
10
100
1,000
10,000
100,000
1,000,000
Tumor Liver Spleen Lungs Heart SkinAcc
umul
atio
n (C
FU
/mg)
Bacteria are Tiny Robot Factories
• Target specific molecular signals
• Can controllably produce therapeutics
Bacterial Accumulation in Cylindroids
100 m
P Q N
Plug
WellPlate
MicroscopeObjective
Cylindroid
96-well plate
Culture Media
Polycarbonate Lid
Cylindroids mimic tumor microenvironments
Control of Cytotoxicity
1. Inject modified bacteria
2. Induce peptide with radiation
Tumor Growth and Mouse SurvivalPBS
Control Bacteria
Cytotoxic Bacteria
PBS + 2Gy
Control Bacteria + 2Gy
Cytotoxic Bacteria + 2Gy
Cytotoxic Bacteria
Control Bacteria
PBS
Bacteria + RadiationControl + 2Gy
PBS + 2Gy
Median survival doubles from 14.0 to 26.0 days
Effect of Double Dose
• Delayed growth 30.3 days
• 30-day survival increased from 0% to 100%
Acknowledgements
Graduate StudentsAdam St. JeanCharley SwoffordBhushan ToleyRaja VenkatasubramanianMiaomin Zhang
Undergraduate StudentsBrett BabinJason LeeMarissa McGarry
AlumniDr. Sabha Ganai, MD PhD
Surgical Oncology, Baystate Medical Center
Dr. Rachel Kasinskas, PhDDr. Byoung-jin Kim, PhDColin Walsh
Collaborators Michael A Henson, PhDRichard B Arenas, MDVincent M Rotello, PhD
FundingNIH, NSFSusan G. Komen For the CureUMass Center for Biomedical ResearchRays of Hope, Springfield, MA
Cells
A
B C